Glutathione (GSH) vs Humanin
Both Glutathione (GSH) and Humanin are used for longevity. Here's how their evidence, dosing, and regulatory status actually compare.
Glutathione (GSH)
Evidence BReduced L-Glutathione
Technically a tripeptide (γ-glutamyl-cysteinyl-glycine) and the body's primary antioxidant. Often grouped with peptide therapy in IV/compounded form for liver support and oxidative stress.
View full Glutathione (GSH) profile →Humanin
Evidence BHumanin (HN)
A 24-amino-acid mitochondrial-derived peptide with cytoprotective effects across Alzheimer's, diabetes, and atherosclerosis preclinical models. Endogenous levels decline sharply with age.
View full Humanin profile →Side-by-Side
| Attribute | Glutathione (GSH) | Humanin |
|---|---|---|
| Evidence Grade | B | B |
| FDA Status | Not FDA-approved as therapeutic — sold as supplement; intravenous use compounded | Not FDA-approved — mitochondrial-derived peptide research compound |
| Typical Dose | 200–600 mg sublingual / 600–2400 mg IV (compounded) | Research range: 0.5–1 mg subcutaneous (rare clinical use) |
| Clinics Indexed | 312 | 5 |
| Categories | antioxidant, longevity | mitochondrial, longevity, neuroprotection |
Key reported benefits — Glutathione (GSH)
- ✓Master antioxidant
- ✓Liver detoxification support
- ✓Oxidative stress reduction
Key reported benefits — Humanin
- ✓Cytoprotection
- ✓Anti-amyloid effects
- ✓Insulin sensitization
Educational use only
This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.